MedTrace Logo

Alternative Diagnoses in Patients About to Start Empiric Tuberculosis Treatment

NCT06737029 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-07-14

No results posted yet for this study

Summary

This study is being conducted to determine whether in patients who are diagnosed with tuberculosis on a clinical basis (where tuberculosis is not found in the sputum) might have other lung diseases than tuberculosis.

Depending on the precise nature of your complaints, additional investigations shall be requested by the study investigators. Possible additional investigations will include laboratory tests on samples of your blood, an additional chest X-ray, lung function testing (where you will have to blow air into a machine, so that your lung capacity is registered), CT-scan, and bronchoscopy.

The information obtained through the investigations done in this study will help in the management of your illness and other patients who are diagnosed with tuberculosis on a clinical basis.

Conditions

Interventions

DIAGNOSTIC_TEST

Enhanced diagnostic workup

Patients will undergo review by a study physician, including a detailed history and physical examination, as well as review of additional investigations that have been performed thus far. Based on the precise nature of the complaints, and additional findings, additional diagnostic testing may be requested, including, but not limited to: blood testing, spirometry, computed tomography of the chest, repeat chest X-ray, sputum investigations, or bronchoscopy.

Sponsors & Collaborators

  • Mr. Willem Bakhuys Roozeboomstichting

    collaborator UNKNOWN

  • Stichting Longartsen voor Afrika

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2026-01-30
Completion
2026-01-30

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06737029 on ClinicalTrials.gov